Relapsing PolychondritisSymptoms, Doctors, Treatments, Advances & More
Relapsing Polychondritis Overview
Learn About Relapsing Polychondritis
- Relapsing polychondritis
- Chronic atrophic polychondritis
- Polychondropathia
- Recurrent polychondritis
Penn Rheumatology University City
Shubhasree Banerjee is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Banerjee is rated as an Elite provider by MediFind in the treatment of Relapsing Polychondritis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Relapsing Polychondritis, Giant Cell Arteritis (GCA), Temporal Arteritis, and Juvenile Temporal Arteritis. Dr. Banerjee is board certified in Rheumatology, 2016 and Internal Medicine, 2013. Dr. Banerjee is currently accepting new patients.
Pacific Medical Centers Specialty Care - Renton
I educate my patients and encourage involvement in the therapeutic decision-making process. Dr. Mendis is rated as an Advanced provider by MediFind in the treatment of Relapsing Polychondritis. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Relapsing Polychondritis, Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), and Polymyositis. Dr. Mendis is board certified in American Board Of Internal Medicine. Dr. Mendis is currently accepting new patients.
Jun Shimizu practices practicing medicine in Tokyo, Japan. Mr. Shimizu is rated as an Elite expert by MediFind in the treatment of Relapsing Polychondritis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Relapsing Polychondritis, Myositis, Inclusion Body Myositis, Neuronal Intranuclear Inclusion Disease (NIID), and Thymectomy.
Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them.
Summary: Open label pragmatic two-stage non-randomized trial comparing the effectiveness of five different standard of care treatment options for patients with relapsing polychondritis (RP).
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
